Category: Press Release - Page 56 - Psychedelic Alpha

Read more about the article COMPASS Pathways plc announces second quarter 2022 financial results and business highlights

COMPASS Pathways plc announces second quarter 2022 financial results and business highlights

Post published:August 4, 2022
Post category:Press Release

Read more about the article MindMed to Participate in the Canaccord Genuity 42nd Annual Growth Conference

MindMed to Participate in the Canaccord Genuity 42nd Annual Growth Conference

Post published:August 4, 2022
Post category:Press Release

Read more about the article Canadian Patent Grant Strengthens Small Pharma’s International Position

Canadian Patent Grant Strengthens Small Pharma’s International Position

Post published:August 4, 2022
Post category:Press Release

Read more about the article Algernon Pharmaceuticals Invited to Present Phase 2 IPF and Chronic Cough Study Data at 9th American Cough Conference

Algernon Pharmaceuticals Invited to Present Phase 2 IPF and Chronic Cough Study Data at 9th American Cough Conference

Post published:August 3, 2022
Post category:Press Release

Read more about the article Braxia Scientific Enters U.S. Telemedicine Industry; Acquires KetaMD, a Mental Health Platform Providing Beneficial Ketamine Treatments in Florida with plans to expand across the U.S.

Braxia Scientific Enters U.S. Telemedicine Industry; Acquires KetaMD, a Mental Health Platform Providing Beneficial Ketamine Treatments in Florida with plans to expand across the U.S.

Post published:August 3, 2022
Post category:Press Release

Read more about the article Incannex Engages Curia to Scale-up Manufacture of cGMP IHL-216A

Incannex Engages Curia to Scale-up Manufacture of cGMP IHL-216A

Post published:August 3, 2022
Post category:Press Release

Read more about the article COMPASS Pathways to participate in upcoming BTIG Biotechnology Conference and Canaccord Annual Growth Conference

COMPASS Pathways to participate in upcoming BTIG Biotechnology Conference and Canaccord Annual Growth Conference

Post published:August 2, 2022
Post category:Press Release

Read more about the article Braxia Scientific Reports Fourth Quarter and FY 2022 Financial Results

Braxia Scientific Reports Fourth Quarter and FY 2022 Financial Results

Post published:August 2, 2022
Post category:Press Release

Read more about the article atai Life Sciences to Announce Second Quarter 2022 Financial Results and Business Update

atai Life Sciences to Announce Second Quarter 2022 Financial Results and Business Update

Post published:August 2, 2022
Post category:Press Release

Read more about the article Algernon Pharmaceuticals Reports Additional Positive Data From its Phase 2 Study of Ifenprodil for IPF and Chronic Cough

Algernon Pharmaceuticals Reports Additional Positive Data From its Phase 2 Study of Ifenprodil for IPF and Chronic Cough

Post published:July 30, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.